ImmunoTox

A guide to the recognition and management of immune-related adverse events from immune checkpoint inhibitors (anti-PD-1, anti-PD-L1, anti-CTLA-4 and anti-LAG-3), for oncologists, emergency physicians, ward doctors and nurses.

Each chapter opens with a Quick action box for the first clinician who sees the patient, then grading, work-up, management by grade, rechallenge and the points where the guidelines differ.